DAE HWA Pharmaceutical Co., Ltd.

KOSDAQ:A067080 주식 보고서

시가총액: ₩225.4b

DAE HWA Pharmaceutical 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Kim Eun-Seok

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권1.1%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

If You Like EPS Growth Then Check Out DAE HWA Pharmaceutical (KOSDAQ:067080) Before It's Too Late

Mar 22
If You Like EPS Growth Then Check Out DAE HWA Pharmaceutical (KOSDAQ:067080) Before It's Too Late

Should DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080) Be Part Of Your Dividend Portfolio?

Jan 28
Should DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080) Be Part Of Your Dividend Portfolio?

Do DAE HWA Pharmaceutical's (KOSDAQ:067080) Earnings Warrant Your Attention?

Dec 06
Do DAE HWA Pharmaceutical's (KOSDAQ:067080) Earnings Warrant Your Attention?

CEO

Kim Eun-Seok (49 yo)

no data

테뉴어

Kim Eun-Seok serves as Chief Executive Officer and External Director of DAE HWA Pharmaceutical Co., Ltd., responsible for planning management. Kim Eun-Seok worked for Bukwang Pharmaceutical Ind. Co., Ltd....